112 related articles for article (PubMed ID: 7899753)
1. [New information on the structure of mycobacteria].
Lagrange PH
Rev Pneumol Clin; 1994; 50(5):199-206. PubMed ID: 7899753
[TBL] [Abstract][Full Text] [Related]
2. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
3. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
4. [The bacteriology of tuberculosis and non-tuberculosis mycobacterial infections].
Wyplosz B; Truffot-Pernot C; Robert J; Jarlier V; Grosset J
Rev Mal Respir; 1997 Dec; 14 Suppl 5():S33-48. PubMed ID: 9496590
[TBL] [Abstract][Full Text] [Related]
5. Tuberculosis one century after R. Koch.
Telenti A
Schweiz Med Wochenschr; 1998 Jan; 128(3):80-3. PubMed ID: 9498259
[TBL] [Abstract][Full Text] [Related]
6. The mycobacterial cell-wall as target for antimycobacterial drugs. I--Synthesis and activity of some diphenylalkylanalogues of mycolic acids.
Leysen DC; Haemers A; Blanchaert L; Van Assche I; Bollaert W; Schoenmaekers K; Pattyn SR
Farmaco Sci; 1987 Nov; 42(11):823-31. PubMed ID: 3127238
[TBL] [Abstract][Full Text] [Related]
7. [Chemical structure of mycobacterial cell wall].
Petit JF
Ann Microbiol (Paris); 1978 Jan; 129(1):39-48. PubMed ID: 350116
[TBL] [Abstract][Full Text] [Related]
8. [View of development of fluoroquinolones].
Namba K
Kekkaku; 1999 Jan; 74(1):47-52. PubMed ID: 10067055
[TBL] [Abstract][Full Text] [Related]
9. Recent developments in molecular biology of mycobacteria.
Grange JM
Bull Int Union Tuberc Lung Dis; 1990; 65(2-3):19-23. PubMed ID: 2257349
[TBL] [Abstract][Full Text] [Related]
10. [Molecular identification of mycobacteria and detection of antibiotic resistance].
Cattoir V
Ann Biol Clin (Paris); 2004; 62(4):405-13. PubMed ID: 15297234
[TBL] [Abstract][Full Text] [Related]
11. Rapid speciation of 15 clinically relevant mycobacteria with simultaneous detection of resistance to rifampin, isoniazid, and streptomycin in Mycobacterium tuberculosis complex.
Shenai S; Rodrigues C; Mehta A
Int J Infect Dis; 2009 Jan; 13(1):46-58. PubMed ID: 18565777
[TBL] [Abstract][Full Text] [Related]
12. [Diagnosis and treatment of mycobacterial infections in patients with HIV/AIDS].
Pulido F; Iribarren JA; Kindelan JM; Moreno S
Enferm Infecc Microbiol Clin; 1998; 16 Suppl 1():20-8. PubMed ID: 9859616
[TBL] [Abstract][Full Text] [Related]
13. Crystallographic studies on the binding of isonicotinyl-NAD adduct to wild-type and isoniazid resistant 2-trans-enoyl-ACP (CoA) reductase from Mycobacterium tuberculosis.
Dias MV; Vasconcelos IB; Prado AM; Fadel V; Basso LA; de Azevedo WF; Santos DS
J Struct Biol; 2007 Sep; 159(3):369-80. PubMed ID: 17588773
[TBL] [Abstract][Full Text] [Related]
14. Ethambutol-induced alterations in Mycobacterium bovis BCG imaged by atomic force microscopy.
Verbelen C; Dupres V; Menozzi FD; Raze D; Baulard AR; Hols P; Dufrêne YF
FEMS Microbiol Lett; 2006 Nov; 264(2):192-7. PubMed ID: 17064372
[TBL] [Abstract][Full Text] [Related]
15. [Recent advances in diagnostic microbiology for mycobacterial infections].
Ichiyama S
Rinsho Byori; 1996 Sep; 44(9):813-7. PubMed ID: 8911064
[TBL] [Abstract][Full Text] [Related]
16. Multicenter evaluation of reverse line blot assay for detection of drug resistance in Mycobacterium tuberculosis clinical isolates.
Mokrousov I; Bhanu NV; Suffys PN; Kadival GV; Yap SF; Cho SN; Jordaan AM; Narvskaya O; Singh UB; Gomes HM; Lee H; Kulkarni SP; Lim KC; Khan BK; van Soolingen D; Victor TC; Schouls LM
J Microbiol Methods; 2004 Jun; 57(3):323-35. PubMed ID: 15134881
[TBL] [Abstract][Full Text] [Related]
17. The Mycobacterium tuberculosis iniA gene is essential for activity of an efflux pump that confers drug tolerance to both isoniazid and ethambutol.
Colangeli R; Helb D; Sridharan S; Sun J; Varma-Basil M; Hazbón MH; Harbacheuski R; Megjugorac NJ; Jacobs WR; Holzenburg A; Sacchettini JC; Alland D
Mol Microbiol; 2005 Mar; 55(6):1829-40. PubMed ID: 15752203
[TBL] [Abstract][Full Text] [Related]
18. [Expectation of new antituberculous drugs and targeting therapy for treatment of mycobacterial infections].
Tomioka H
Kekkaku; 1993 Nov; 68(11):723-30. PubMed ID: 8264129
[TBL] [Abstract][Full Text] [Related]
19. A review of vaccine research and development: tuberculosis.
Girard MP; Fruth U; Kieny MP
Vaccine; 2005 Dec; 23(50):5725-31. PubMed ID: 16153751
[TBL] [Abstract][Full Text] [Related]
20. Identification and structural characterization of an unusual mycobacterial monomeromycolyl-diacylglycerol.
Kremer L; de Chastellier C; Dobson G; Gibson KJ; Bifani P; Balor S; Gorvel JP; Locht C; Minnikin DE; Besra GS
Mol Microbiol; 2005 Aug; 57(4):1113-26. PubMed ID: 16091048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
